Participants with other active malignancy requiring concurrent intervention
Other active malignancy requiring concurrent intervention
Subjects with other active malignancy requiring concurrent intervention
Other active malignancy that is progressing, requires concurrent intervention, and/or could be mistaken for the malignancy under study during disease assessments
Concurrent active malignancy requiring immediate therapy
Pts receiving active treatment or intervention for any other malignancy or pts who, at the Investigator's discretion, may require active treatment or intervention for any other malignancy within 8 months of starting study treatment.
Participants with other active malignancy requiring concurrent intervention
Participants with any other active malignancy requiring concurrent intervention
Uncontrolled concurrent malignancy (early stage is allowed if not requiring active therapy or intervention)
Active concurrent malignancy requiring active therapy
Participants with other active malignancy requiring concurrent intervention
Other active malignancy requiring concurrent intervention
Participants must not have other active malignancy requiring concurrent intervention
Other active malignancy requiring concurrent intervention.
Concurrent malignancy requiring cytotoxic or immunotherapy based treatment
Other active malignancy requiring concurrent intervention; a history of prior malignancy will not be an exclusion factor as long as the patient is not currently requiring treatment for this malignancy
Diagnosed with another concurrent malignancy requiring treatment
Other active malignancy requiring concurrent intervention
Patients receiving active treatment or intervention for any other malignancy or patients who, at the investigatorâ€™s discretion, may require active treatment or intervention for any other malignancy within 8 months of starting study treatment
Concurrent malignancy requiring active therapy
Other active malignancy requiring concurrent intervention
Concurrent malignancy other than the solid tumor under investigation, requiring\n             active treatment.
Subject has another active malignancy requiring concurrent intervention;
Other active malignancy requiring concurrent intervention
Concurrent malignancy requiring active therapy \r\n* Patients with more than one type of lymphoma may be enrolled after discussion with the MSK principal investigator
Patient has an active concurrent malignancy requiring active therapy
Active concurrent malignancy requiring active therapy
Active concurrent malignancy requiring active therapy
Concurrent active malignancy requiring immediate therapy
An active malignancy that requires concurrent intervention
Concurrent active malignancy requiring immediate therapy
Concurrent active malignancy other than AML requiring therapy
Concurrent active malignancy requiring systemic treatment
No concurrent malignancy with a life expectancy of less than two years, or one that requires ongoing chemotherapeutic intervention at screening
Patients receiving active treatment or intervention for any other malignancy or patients who, at the Investigator's discretion, may require active treatment or intervention for any other malignancy within 8 months of starting study treatment.
Patient has an active concurrent malignancy requiring active therapy
Concurrent malignancy requiring active treatment with chemotherapy, immunotherapy, or radiation
